As the healthcare sector leaned heavily on technology during the COVID-19 pandemic, interpreters reported mixed experiences that raises serious questions about the effectiveness of remote communication platforms in critical medical settings.
Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats | Psychedelic Invest
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural